Law360, New York (February 22, 2011, 6:18 PM ET) -- Sun Pharmaceutical Industries Ltd. will acquire the remaining 24 percent of Caraco Pharmaceutical Laboratories that it does not already own, the companies said Tuesday, further consolidating the generic-drug makers into a formidable market player.
The deal, valuing Caraco's stock at $5.25 a share, was struck Monday, Caraco announced.
Sun Pharma and subsidiary Sun Pharma Global Inc. had previously proposed a transaction to go private, by which the companies or one or more of their affiliates would acquire all of the outstanding shares of Caraco common stock...
Sun Pharma Buys Out Remainder Of Caraco
To view the full article, take a free trial now.
